Denaverine

Denaverine

Clinical data
AHFS/Drugs.com	International Drug Names
Pregnancy category	Gr 1 (Germany)
Routes of administration	intramuscular injection, suppositories
ATCvet code	Template:Infobox drug/formatATCvet Template:Infobox drug/formatATCvet
Legal status
Legal status	In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	8% (suppositories), 37% (oral solution)
Metabolism	mainly hepatic, at least 11 metabolites
Elimination half-life	34 hours
Identifiers
IUPAC name 2-(Dimethylamino)ethyl (2-ethylbutoxy)diphenylacetate
CAS Number	3579-62-2 Y 3321-06-0 (hydrochloride)
PubChem CID	71130
ChemSpider	64278 N
UNII	O14NF38MTL
KEGG	D07787 Y
ChEMBL	ChEMBL1614656 N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C24H33NO3
Molar mass	383.52 g/mol
3D model (JSmol)	Interactive image
SMILES CCC(CC)COC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(C)C
InChI InChI=1S/C24H33NO3/c1-5-20(6-2)19-28-24(21-13-9-7-10-14-21,22-15-11-8-12-16-22)23(26)27-18-17-25(3)4/h7-16,20H,5-6,17-19H2,1-4H3 N Key:FPTOUQZVCUIPHY-UHFFFAOYSA-N N
NY (what is this?)  (verify)

WikiDoc Resources for Denaverine
Articles
Most recent articles on Denaverine Most cited articles on Denaverine Review articles on Denaverine Articles on Denaverine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Denaverine Images of Denaverine Photos of Denaverine Podcasts & MP3s on Denaverine Videos on Denaverine
Evidence Based Medicine
Cochrane Collaboration on Denaverine Bandolier on Denaverine TRIP on Denaverine
Clinical Trials
Ongoing Trials on Denaverine at Clinical Trials.gov Trial results on Denaverine Clinical Trials on Denaverine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Denaverine NICE Guidance on Denaverine NHS PRODIGY Guidance FDA on Denaverine CDC on Denaverine
Books
Books on Denaverine
News
Denaverine in the news Be alerted to news on Denaverine News trends on Denaverine
Commentary
Blogs on Denaverine
Definitions
Definitions of Denaverine
Patient Resources / Community
Patient resources on Denaverine Discussion groups on Denaverine Patient Handouts on Denaverine Directions to Hospitals Treating Denaverine Risk calculators and risk factors for Denaverine
Healthcare Provider Resources
Symptoms of Denaverine Causes & Risk Factors for Denaverine Diagnostic studies for Denaverine Treatment of Denaverine
Continuing Medical Education (CME)
CME Programs on Denaverine
International
Denaverine en Espanol Denaverine en Francais
Business
Denaverine in the Marketplace Patents on Denaverine
Experimental / Informatics
List of terms related to Denaverine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Denaverine is an antispasmodic drug. It was developed in Germany and patented in 1974. Denaverine hydrochloride is used in veterinary medicine under the trade name Sensiblex as a muscle relaxant for the myometrium of cows and dogs during childbirth. Under the trade name Spasmalgan, it has also been used in humans for the treatment of urogenital and gastrointestinal spasms.

Mechanism of action

Denaverine, like papaverine, acts as a phosphodiesterase inhibitor. Additionally, it has anticholinergic effects.